This is Guru Focus Market Today, your afternoon market brief for Wednesday, August 19th. Here's where things stand. Major US stock indices rebounded sharply, snapping a 3-day losing streak as the Dow, S&P 500, and Nasdaq all posted gains.The rally was driven by a recovery in bond markets and strong performance from MADNA which surged on positive clinical trial results. The rebound followed a period of volatility linked to rising yields and global bond market declines. Turning now to Madna and Merc.The two c ...

Moderna co-founder Robert Langer is a billionaire once again, according to Forbes’ estimates, as shares in the biotech giant doubled in value on Wednesday following positive results from a late-stage trial of a cancer vaccine. https://t.co/SPaMNkjkKa ...

Moderna ($MRNA) is the biotech behind one of the fastest vaccine developments in history, home to an mRNA platform spanning COVID, RSV, flu, and individualized cancer treatment.Verify the address on @tokens: https://t.co/aMUWruvyLK ...

BREAKING: $MRNA from Moderna is live on Solana via @sunrise, issued by @Backpack SecuritiesModerna announced the first ever positive Phase 3 results for a personalized cancer vaccinehttps://t.co/vkyVEQeuYpNone (@None):Sunrise has listed $MRNA on @Solana.Today, Moderna and Merck reported the first positive Phase 3 results for an mRNA cancer therapy.Issued by @Backpack Securities, a tokenized Moderna share now trades on Solana, 24/7. https://t.co/uqGE6y1HXH ...

And right now we are two minutes away from the end of the trading day. Romaine Bostick here with Isabelle Lee taking you through to that closing bell. It's a global simulcast.Carol Massar joins us from the radio booth. Emily fell in today for Tim Stenbeck. Welcome to our audiences across all of our Bloomberg platforms.Television, radio. Our partnership with YouTube, the S&P 500, trying to recoup some of the losses from the previous three sessions, but only up right now about 15 points or 2/10 of 1%. Yeah, I ...

Moderna co-founder Robert Langer is a billionaire once again, according to Forbes’ estimates, as shares in the biotech giant doubled in value on Wednesday following positive results from a late-stage trial of a cancer vaccine.Read more: https://t.co/gEPzuLJKNUPhoto: Taylor Hill via Getty Images ...

>> LIVE FROM WASHINGTON DC, THIS IS "BALANCE OF POWER" WITH JOE MATHIEU AND KAILEY LEINZ. KAILEY: THE TRUMP ADMINISTRATION IS WATCHING THE BOND MARKET, CANADA AND TECH. WELCOME TO "BALANCE OF POWER." THE PRESIDENT PUNTING ON NEW CANADIAN TARIFFS THAT WERE SET TO GO INTO EFFECT TODAY AND INSTEAD SHIFT HIS FOCUS TO A MEETING AT THE WHITE HOUSE THIS AFTERNOON WITH THE LEADERS OF BIG TECH AND CRYPTO COMPANIES.WE GET THE LATEST FROM THE WHITE HOUSE FROM BLOOMBERG'S TYLER KENDALL, AND TALK ABOUT THE CEOS WHO WERE ...

$MRNA is onchain & trending with $28.3M traded in 24h.Moderna announced positive Phase 3 results today for its mRNA melanoma therapy.$MRNA is accessible as perpetual markets or RWAs on Trust Wallet. https://t.co/kbd6JzI1t1 ...

Moderna shares more than doubled after its personalized cancer vaccine cleared a late-stage melanoma trialThe shot, intismeran, is tailored to mutations in each patient's tumor and was tested alongside Merck's Keytruda. Patients on the combination went longer without the cancer returning or spreading than those on Keytruda alone.The treatment is not approved and @moderna_tx released initial results only. $MRNA traded at $158.29 against a previous close of $62.96, with short sellers facing about $5B in losse ...

Bring in show music, please. >> Hi, I'm CNBC producer Katie Kramer. Today on Squawk Pod, the promise of a personalized cancer vaccine.We have the CEO of Madna, Stefan Bonscel. >> It's a big moment for medicine, big moment for patients. >> Milestone experimental results that could extend life for patients with the deadly diagnosis of melanoma.MK's Dr. . Dean Lee. We don't know if this is going to be 7 years, 9 years, but there's a chance that you have an increased ability to be disease-free and for a potenti ...